Core & Trust
About Tirzepatide Ranked
Who publishes this and how it is funded
Tirzepatide Ranked is published by S.J Partners LLC. We research what GLP-1 care costs in the United States, what providers actually promise, and what the clinical evidence does and does not establish. We are not a clinic, a pharmacy or a manufacturer.
Tirzepatide Ranked is published by S.J Partners LLC. We research what GLP-1 care costs in the United States, what providers actually promise, and what the clinical evidence does and does not establish. We are not a clinic, a pharmacy or a manufacturer.
Our test for every page is simple: could a reader check our work? If a number appears without a dated source, it should not have been published.
Show this figure as a table
| Status | Records | Share |
|---|---|---|
| Verified | 15 | 26% |
| Provider-reported | 36 | 63% |
| Pending capture | 6 | 11% |
| Outdated | 0 | 0% |
| Sample placeholder | 0 | 0% |
| Area | Commitment | How you can check it |
|---|---|---|
| Every figure | Carries a source and a capture date | Open the provenance stamp beside it |
| Every clinical claim | Traced to a primary source | Follow the citation, not our summary |
| Every score | Computed from published inputs | Read the raw inputs on the provider page |
| Every correction | Dated and permanent | Read the corrections log |
| Every medical review | Dated on the page | Read “Last medically reviewed” in the byline |
A dash means no figure held. How we grade evidence.
Who we are
Tirzepatide Ranked is published by S.J Partners LLC. The publisher is accountable for everything on the site: the rankings, the prices, the trial summaries, the corrections and the policies.
Research is led by Dr. Parmis, a medical researcher (Western University of Health Sciences), who traces each clinical claim back to its trial publication, trial registry entry or regulatory record. Clinical content is medically reviewed by Dr. Jonathan Snipes, MD (NPI 1821250077) and Kim Callender, NP (FNP-BC, NPI 1144661760), who check claims against those primary sources before a page publishes. Prices are read on each seller's own page, and the date we read them sits beside the figure.
What we are not:
- We are not a clinic. Nobody here prescribes or gives individual medical advice.
- We are not a pharmacy. We do not compound, dispense, sell or ship medicine.
- We are not a manufacturer.
- We do not collect your health details, and no page or tool on the site asks for them.
How this is funded
Tirzepatide Ranked is affiliate-supported. When you enroll with a provider through a link on this site, we may earn a commission.
That gives us a reason to favour whichever program pays, so the rules that keep money away from editorial decisions are fixed and public:
- Scores come from the published methodology, version 4.1: seven categories, 100 points, with the inputs shown on each provider page.
- Every price carries the date we read it on the seller's own page. See how we verify a price.
- Mistakes are logged with a date and left visible on the corrections log.
- Any provider we name can contest a fact, figure or score through the right to respond.
Compensation never changes our methodology, rankings or the prices we report. The full terms are in the affiliate and commercial disclosure.
What we publish and what we refuse to publish
We publish dated prices, scored rankings, trial summaries that keep every figure tied to its trial, dose and estimand, and plain explanations of FDA actions. We also publish our own gaps: a record we have not yet captured is shown as pending, not filled in with a guess.
We refuse to publish:
- Any description of compounded tirzepatide as FDA-approved, as generic, or as the same product as Zepbound or Mounjaro. It is made with the drug in those products. It is not the same product.
- Promises of weight loss. A trial result is a group average, not a forecast for you.
- Prices copied from other review sites. If we could not read a figure on the seller's own page, we do not report it as a price.
- "Cheapest" or "best" with nothing attached. The plan type, dose and date have to travel with the claim.
- Dosing advice for an individual reader.
- Placement, scores or reviews in exchange for payment.
How to check our work
You should be able to trace any number on this site to its source in about a minute. Four places let you do it:
- Source ledger: each evidence ID, the source it points to and the date it was read.
- Price records and the wider datasets: the figures behind the price index, in CSV and JSON. The index was last re-read on October 15, 2026: 33 compounded tirzepatide programs, $69 to $299 a month all-in, median $149. Twenty-three were read on the sellers' pages that day; five are older records and carry their older dates.
- Methodology: the v4.1 rubric and the rules that override any score.
- Methodology and dataset changelog: what changed in the rubric or the data, and when.
If what you find does not match what we published, tell us through the contact page. If we are wrong, the fix goes on the corrections log with the old wording still visible.
NexLife, first on our v4.1 methodology, charges $129 a month for compounded tirzepatide month to month, or $115 a month on a 12-month plan, with one price at every dose and no membership fee (read on nexlife.us, November 6, 2026). Check its current plans (opens nexlife.us in a new tab).
Related on this site
- Tirzepatide Ranked: Evidence, Prices, Providers & ToolsCore & Trust
- Editorial StandardsCore & Trust
- Provider Ranking MethodologyCore & Trust
- Medical Review ProcessCore & Trust
- Cost calculatorTools
- The underlying price recordsData
- Corrections and Update LogCore & Trust
- Contact the Editorial TeamCore & Trust
- Conflicts of Interest PolicyCore & Trust
- AI Use PolicyCore & Trust
Related coverage
- Zepbound Savings: Every Legitimate Route, and What Each Actually Costs
- Compounded tirzepatide price index
- What you pay at a maintenance dose
- Best Tirzepatide Providers Online in 2026
- Cheapest Compounded Tirzepatide Online: Entry Price vs What You Pay
- Cheapest Compounded Tirzepatide: Ongoing Costs Compared
- Cheapest Online Tirzepatide Providers: Every Route, Ranked by Annual Cost
- Cheapest Tirzepatide Online in 2026: Microdose, Compounded and Brand
- Tirzepatide and GLP-1 Comparisons
Tirzepatide Ranked. “About Tirzepatide Ranked.” S.J Partners LLC, 2026-07-26. https://tirzepatideranked.com/about/
Quote the capture date beside a figure, not the date you read this page. Why.